Benliu Journalist learned from the Gansu Provincial Department of Science and Technology on September 5 that the Gansu Pharmaceutical Investment Group and related colleges, medical institutions, scientific research institutes, and Chinese medicine enterprises were jointly launche

Benliu News reporter learned from the Gansu Provincial Department of Science and Technology on September 5 that Gansu Traditional Chinese Medicine was jointly established by Gansu Pharmaceutical Investment Group and 39 units including relevant universities, medical institutions, scientific research institutes and traditional Chinese medicine companies. The Industrial Innovation Consortium, under the joint guidance and support of the Gansu Provincial Department of Science and Technology and the Gansu Provincial Department of Industry and Information Technology, has recently been officially approved for registration after several rounds of expert consultations that lasted about half a year.

The traditional Chinese medicine industry, as an important part of the biomedical industry , is a key industrial chain in Gansu. Over the years, Gansu has made concentrated efforts in policy guidance, platform building, R&D and production, and expansion of financing channels to support the high-quality development of the traditional Chinese medicine industry. At present, the annual output value of the whole industry chain of traditional Chinese medicine in Gansu Province is 52 billion yuan. There is one traditional Chinese medicine manufacturer with an annual output value of more than 1 billion yuan, 3 companies with an annual output value of more than 500 million yuan, 21 companies with an annual output value of more than 100 million yuan, and 13 traditional Chinese medicine manufacturers with sales of more than 100 million yuan. It is rich in traditional Chinese medicine resources and has a good foundation for innovative research and development.

has established an innovative consortium in the field of traditional Chinese medicine, aiming to strengthen the interconnection between colleges and universities, scientific research institutes, pharmaceutical companies, and medical institutions in the field of traditional Chinese medicine in the province, and jointly develop the traditional Chinese medicine industry based on the advantages of Gansu's unique traditional Chinese medicine resources. Research on major common technologies and key technologies, and promote the talent chain, industrial chain, project chain, technology chain, and capital of each unit within the consortium With the integration of the "five chains" of the chain, we will explore a new collaborative innovation mechanism that includes government guidance, enterprise proposal, multi-party funding, scientific and enterprise joint research, and result sharing. We will continue to promote the integration of high-quality resources in Gansu's traditional Chinese medicine industry and integrate traditional Chinese medicine resources in Gansu Province. Advantages are transformed into economic advantages, realizing a high-quality traditional Chinese medicine industry development model that benefits the northwest region of Gansu Province, and enhancing the core competitiveness of Gansu Province's biopharmaceutical industry.

text丨Benliu News reporter Wu Yongming